Latest Articles

Publication Date
Combination of immunotherapy and chemotherapy as first-line treatment for advanced or recurrent endometrial cancer: a meta-analysis of phase 3 trials - BMC Cancer

Combination of immunotherapy and chemotherapy as first-line treatment for advanced or recurrent endometrial cancer: a meta-analysis of phase 3 trials BMC Cancer

Published: Oct. 14, 2025, 2:41 p.m.
New treatment option for endometriosis approved in Scotland - PharmaTimes

New treatment option for endometriosis approved in Scotland PharmaTimes

Published: Oct. 13, 2025, 11:09 a.m.
“I lost my dreams”, says woman who became paraplegic after treatment for endometriosis - lnginnorthernbc.ca

“I lost my dreams”, says woman who became paraplegic after treatment for endometriosis lnginnorthernbc.ca

Published: Oct. 12, 2025, 7:44 a.m.
New treatment for endometriosis now available in NZ - 1News

New treatment for endometriosis now available in NZ 1News

Published: Oct. 10, 2025, 10:26 p.m.
New treatment for endometriosis now available in NZ - Otago Daily Times

New treatment for endometriosis now available in NZ Otago Daily Times

Published: Oct. 9, 2025, 1 a.m.
New treatment for endometriosis now available in New Zealand - RNZ

New treatment for endometriosis now available in New Zealand RNZ

Published: Oct. 8, 2025, 8:23 p.m.
New treatment for endometriosis is now available in NZ - RNZ

New treatment for endometriosis is now available in NZ RNZ

Published: Oct. 8, 2025, 7:56 p.m.
Hope Medicine Completes Phase 2 Trial of Non-Hormonal Endometriosis Treatment - Femtech Insider

Hope Medicine Completes Phase 2 Trial of Non-Hormonal Endometriosis Treatment Femtech Insider

Published: Oct. 8, 2025, 7:30 p.m.
Hope Medicine Ready To Bring Potential First-in-Class Endometriosis Treatment Into Phase III - insights.citeline.com

Hope Medicine Ready To Bring Potential First-in-Class Endometriosis Treatment Into Phase III insights.citeline.com

Published: Oct. 8, 2025, 2:15 p.m.
Apotex Strengthens Commitment to Women's Health with Exclusive Canadian Rights to "Linzagolix" for Uterine Fibroid Treatment - The Malaysian Reserve

Apotex Strengthens Commitment to Women's Health with Exclusive Canadian Rights to "Linzagolix" for Uterine Fibroid Treatment The Malaysian Reserve

Published: Oct. 8, 2025, 10:56 a.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!